Treatment of nocturia in the elderly

Drugs and Aging

Volumn 15, Issue 6, 1999, Pages 429-437

  Kallas, Henrique E ^a   Chintanadilok, Jirayos ^a   Maruenda, Javier ^a   Donahue, James L ^a   Lowenthal, David T ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESMOPRESSIN; ENZYME INHIBITOR; LOOP DIURETIC AGENT; NARCOTIC AGENT; NEUROLEPTIC AGENT; OXIDOREDUCTASE; SPASMOLYTIC AGENT;

AGED; AGING; BLADDER NECK STENOSIS; BLADDER STONE; BLADDER TUMOR; DISEASE ASSOCIATION; ELECTROSTIMULATION; HUMAN; MICTURITION; MUSCLE HYPOTONIA; NOCTURIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; SPINAL CORD LESION; URETER CATHETERIZATION; URINARY EXCRETION; URINARY TRACT; URINE OSMOLALITY; URINE VOLUME;

EID: 0033395818     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199915060-00003     Document Type: Review

References (58)

1. 1. Malmsten UG, Milsom I, Molander U, et al. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years. J Urol 1997; 158 (5): 1733-7
2. 2. Saito M, Kondo A, Kato T, et al. Frequency-volume charts: comparison frequency between elderly and adult patients. Br J Urol 1993; 72: 38-41
3. 3. Asplund R, Aberg HE. Micturition habits of older people, voiding frequency and urine volumes. Scand J Urol Nephrol 1992; 26: 345-9
4. 4. Kirkland JL, Lye M, Levy DW, et al. Patterns of urine flow and electrolyte excretion in healthy elderly people. BMJ 1983; 287: 1665-7
5. 5. Ouslander J, Schnelle J, Simmons S, et al. The dark side of incontinence: nighttime incontinence in nursing home residents. J Am Geriatr Soc 1993; 41: 371-6
6. 6. Asplund R. The nocturnal polyuria syndrome (NPS). Gen Pharmacol 1995; 26: 1203-9
7. 7. Lindeman RD. Renal and urinary tract function. In: Masoro EJ, editor. Aging. New York (NY): Oxford Press, 1995: 485-504
8. 8. Donahue JL, Lowenthal DT. Nocturnal polyuria in the elderly person. Am J Med Sci 1997; 314: 232-38
9. 9. Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med 1991; 229: 131-4
10. 10. Standaert DG, Cechetto DF, Needleman P, et al. Inhibition of the firing of vasopressin neurons by atriopeptin. Nature 1987; 329: 151-3
11. 11. Needleman P, Greenwald JE. Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med 1986; 314: 828-34
12. 12. Tan T, Hoefnagels W, Swinkels LM, et al. The effect of volume expansion on atrial natriuretic peptide and cyclic guanosine monophosphate levels in young and aged subjects. J Am Geriatr Soc 1990; 38: 1215-9
13. 13. Haller BG, Zust H, Shaw S, et al. Effects of posture and ageing on circulating atrial natriuretic peptide levels in man. J Hypertens 1987; 5: 551-6
14. 14. Ohashi M, Fujio N, Nawata H, et al. High plasma concentrations of human atrial natriuretic polypeptide in aged men. J Clin Endocrinol Metab 1987; 64: 81-5
15. 15. Quay W. Diffuse endocrine and chemical mediators. ln:Timiras P, Quay W, Vernadakis A, editors. Hormones and aging. Boca Raton (FL): CRC Press. 1995: 107-20
16. 16. Resnick NM. Voiding dysfunction in the elderly. In: Yalla SV, McGuire EJ, Elbadawi A, et al, editors. Neurourology and urodynamics: principles and practice. New York (NY): Macmillan Publishing Co. Inc., 1988: 303-30
17. 17. Diokno AC, Brown MB, Brock BM, et al. Clinical and cystometric characteristics of continent and incontinent noninstitutionalized elderly. J Urol 1998; 140: 567-71
18. 18. Resnick NM. Urinary incontinence in older adults. Hosp Pract 1992; 27 (10): 552-66
19. 19. Mold JW. Pharmacotherapy of urinary incontinence. Am Fam Physician 1996; 54: 673-80
20. 20. Burgio KL, Locher JL, Ives DG, et al. Nocturnal enuresis in community-dwelling older adults. J Am Geriatr Soc 1996; 44 (2): 139-43
21. 21. Fantl JA, Wyman JF, Harkins SW, et al. Bladder training in the management of lower urinary tract dysfunction in women: a review. J Am Geriatr Soc 1990, 38: 329-32
22. 22. Fantl JA, Wyman JF, McClish DK, et al. Efficacy of bladder training in older women with urinary incontinence. JAMA 1991; 265: 609-13
23. 23. Brubaker L, Benson JT, Bent A, et al. Transvaginal electrical stimulation for female urinary incontinence. Am J Obstet Gynecol 1997; 177: 536-40
24. 24. Gibaldi M, Grundhofer B. Biopharmaceutical influences on the anticholinergic effects of propantheline. Clin Pharmucol Ther 1975; 18: 457-61
25. 25. Moore KH, Hay DM, Imric AE, et al. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability. Br J Urol 1990; 66: 479-85
26. 26. Castleden CM, Duffin HM, Gulati RS. Double blind study of imipramine and placebo for incontinence due to bladder instability. Age Ageing 1986; 15: 299-303
27. 27. Lose G, Jorgensen L, Thunedborg P. Doxepin in the treatment of female detrusor overactivity: a randomized double-blind crossover study. J Urol 1989; 142: 1024-6
28. 28. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hyperplasia in the community. Lancet 1991; 338: 469-71
29. 29. Chutka DS, Takahashi PY. Urinary incontinence in the elderly: drug treatment options. Drugs 1998; 56: 587-95
30. 30. Gillenwater JY, Conn RL, Chrysant SG, et al. Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study. J Urol 1995; 154: 110-5
31. 31. Lepor H, Auerbach S, Puras-Baez A, et al. A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol 1992; 148: 1467-74
32. 32. Noble AJ, Chess-Williams R, Couldwell C, et al. The effects of tamsulosin, a high affinity antagonist at functional alpha 1A and alpha 1D-adrenoceptor subtypes. Br J Pharmacol 1997; 120: 231-8
33. 33. Chappile CR, Baert L, Thind P, et al. Tamsulosin 0.4mg once daily: tolerubility in older and younger patients with lower urinary tract symptoms suggestive of BPH (symptomatic BPH), the European Tamsulosin Study Group. Eur Urol 1997; 32 (4): 462-70
34. 34. Lowe FC. Coadministration of tamsulosin and three antihypertensive agents in patients with BPH: pharmacodynamic effect. Clin Ther 1997; 19 (4): 730-42
35. 35. Lowenthal DT, Maruenda J, Chintanadilok J, et al. Clinical pharmacology-physiology conference: the hypertensive elderly male with prostatism. Geriatr Nephrol Urol 1999; 9; 57-60
36. 36. Moore E, Bracken B, Bremner W, et al. Proscar: five year experience. Eur Urol 1995; 28: 304-9
37. 37. Boyle P, Gould AL. Prostate volume predicts outcome of treatment of BPH with finasteride: meta-analysis of randomized clinical trials. Urology 1996; 48: 398-405
38. 38. Lepor H, Williford WO, Barry MJ, et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N Engl J Med 1996; 335: 533-9
39. 39. Berges RR, Windeler J, Trampisch HJ, et al. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Lancet 1995; 345: 1529-32
40. 40. Lowe FC, Ku JC. Phytotherapy of benign prostatic hyperplasia: a critical review. Urology 1996; 48 (1): 12-20
41. 41. Ziada A, Rosenblum M, Crawford ED. Benign prostatic hyperplasia: an overview. Urology 1999; 53 (3 Suppl. 3a): 1-6
42. 42. Chutka DS, Fleming KC, Evans MP, et al. Urinary incontinence in the elderly population. Mayo Clin Proc 1996; 71: 93-101
43. 43. Ulfberg J, Thuman R. A non-urologic cause of nocturia and enuresis-obstructive sleep apnea syndrome (OSAS). Scand J Urol Nephrol 1996; 30 (2): 135-7
44. 44. Krieger J. Mechanisms of daytime pulmonary hypertension and altered renal function in obstructive sleep apnea. In: Guilleminault C, Partinen M, editors. Obstructive sleep apnea syndrome: clinical research and treatment. New York (NY): Raven Press, 1990: 71-9
45. 45. Reynard JM, Cannon A, Yang Q, et al. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol 1998; 81: 215-8
46. 46. Pedersen PA, Johansen PB. Prophylactic treatment of adult nocturia with bumetanide. Br J Urol 1998; 62 (2): 145-7
47. 47. Physician's desk reference. Oradell (NJ): Medical Economics, 1997: 2180-2
48. 48. Eckford SD, Swami KS, Jackson SR, et al. Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis. Br J Urol 1994; 74: 738-5
49. 49. Valiquette G, Abrams GM, Herbert J. DDAVP in the management of nocturia in multiple sclerosis [lelter]. Ann Neurol 1992; 31: 577
50. 50. Hilton P, Hertogs K, Stanton SL. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Ncurosurg Psychiatry 1983; 46: 854-5
51. 51. Eckford SD, Carter PG, Jackson SR, et al. An open, in-patient incremental safety and efficacy study of desmopressin in women w iih multiple sclerosis and nocturia. Br J Urol 1995; 76: 459-63
52. 52. Mathias CJ, Fosbraey P, Da CD, et al. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. BMJ 1986; 293: 353-4
53. 53. Suchowersky O, Furtado S, Rohs G. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease. Mov Disord 1995; 10: 337-40
54. 54. Mansson W, Sundin T, Gullberg B. Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy: a double-blind study. Scand J Urol Nephrol 1980; 14: 139-41
55. 55. Hilton P, Stanton SL. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Br J Urol 1982; 54: 252-5
56. 56. Asplund R, Sundberg B, Bengtsson P. Desmopressin for the treatment of nocturnal polyuria in the elderly subjects: a dose titration study. Br J Urol 1998; 82: 642-6
57. 57. Asplund R, Sundberg B, Bengtsson P. Oral desmopressin for nocturnal polyuria in 60-74 year old subjects: a double-blind, placebo-controlled and randomised exploratory study. Br J Urol 1999; 83: 591-5
58. 58. Carter PG, McConnell AA, Abrams P. The safety and efficacy of DDAVP in the elderly. Neurourol Urodyn 1992; 11: 421-2